対人恐怖症治療のグローバル臨床試験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Social Phobia Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Social Phobia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Social Phobia to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Social Phobia 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Social Phobia Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
GlaxoSmithKline plc 27
Clinical Trial Overview of GlaxoSmithKline plc 27
Pfizer Inc. 28
Clinical Trial Overview of Pfizer Inc. 28
Eli Lilly and Company 29
Clinical Trial Overview of Eli Lilly and Company 29
Pherin Pharmaceuticals, Inc. 30
Clinical Trial Overview of Pherin Pharmaceuticals, Inc. 30
Neurocrine Biosciences, Inc. 31
Clinical Trial Overview of Neurocrine Biosciences, Inc. 31
Mylan Inc. 32
Clinical Trial Overview of Mylan Inc. 32
Avera Pharmaceuticals, Inc. 33
Clinical Trial Overview of Avera Pharmaceuticals, Inc. 33
Apsen Farmaceutica SA 34
Clinical Trial Overview of Apsen Farmaceutica SA 34
Clinical Trial Overview of Top Institutes / Government 35
The University of New South Wales 35
Clinical Trial Overview of The University of New South Wales 35
National Institute of Mental Health 36
Clinical Trial Overview of National Institute of Mental Health 36
Umea University 37
Clinical Trial Overview of Umea University 37
Massachusetts General Hospital 38
Clinical Trial Overview of Massachusetts General Hospital 38
Karolinska Institute 39
Clinical Trial Overview of Karolinska Institute 39
University of California, Los Angeles 40
Clinical Trial Overview of University of California, Los Angeles 40
University of South Florida 41
Clinical Trial Overview of University of South Florida 41
University of Pittsburgh 42
Clinical Trial Overview of University of Pittsburgh 42
Macquarie University 43
Clinical Trial Overview of Macquarie University 43
Hamilton Health Sciences 44
Clinical Trial Overview of Hamilton Health Sciences 44
Five Key Clinical Profiles 45
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71


【レポート販売概要】

■ タイトル:対人恐怖症治療のグローバル臨床試験動向(2014年下半期)
■ 英文:Social Phobia Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC2277CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。